Navigation Links
Scientific Luminaries to Keynote at 3rd Annual PODD
Date:6/12/2013

New York, New York (PRWEB) June 12, 2013

The Conference Forum is pleased to announce the keynotes for the 3rd annual PODD: Partnership Opportunities in Drug Delivery event, which takes place on October 10-11 in Boston. PODD is strategic level networking event designed to bring drug delivery innovators together with key decision makers at pharmaceutical, biotechnology and medical device companies. This event provides the opportunity to learn about cutting-edge delivery technologies and meet with senior level executives and scientists.

To kick-off the PODD event, Robert Langer, PhD, David H. Koch Institute Professor at MIT will engage in a fireside style chat to discuss the difference between success and failure of drug delivery technologies.

On the second day of the conference George M. Whitesides, PhD, Woodford L. and Ann A. Flowers University Professor, Harvard University and Founding Core Faculty Member, Wyss Institute will address how drug delivery will disrupt the future of healthcare.

PODD is chaired by Barbara Lueckel, PhD, Global Business Development Director, Roche and features a wide range of drug delivery technologies, pharmaceutical and biotech business development panels, together with new discussions related to delivering biologics, role of drug delivery in the R&D pipeline, nanomedicine, and funding in the drug delivery sector.

We are excited to bring all the major components together that advance drug delivery partnerships," Valerie Bowling, Executive Director of the Conference Forum.

Other conference highlights include:
    ?    How drug delivery is disrupting the diagnostics industry
    ?    Who is funding drug delivery
    ?    The next paradigm on how biologics will be delivered
    ?    New deal structures and models
    ?    POV from heads of R&D on the role of drug delivery
    ?    Partnering and networking tools and facilities

To learn more about the PODD conference, visit http://www.theconferenceforum.org.

About the Conference Forum

The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Related Links:
Dr Robert S. Langer, PhD, Biography
Dr George Whitesides, PhD, Biography
Barbara Lueckel, PhD, Biography

Read the full story at http://www.prweb.com/releases/2013/6/prweb10813366.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Steep Hill Laboratories and Halent Scientific Proudly Announce Historic Merger
2. Used Scientific Equipment Supplier, BMI Surplus, Partners with Universities During Sequester
3. Hemostemix Announces Formation of Scientific Advisory Board
4. DuPont Celebrates Scientific Innovation by Recognizing Young Professors
5. Pioneering Researchers Recognized for Scientific Achievements in Gene and Cell Therapy
6. Trigemina Presents at American Pain Society 32nd Annual Scientific Meeting
7. Emory Cardiologists Arshed Quyyumi And Javed Butler Join Stemedica Cardiology Division Scientific Advisory Board
8. Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCalls Microscope
9. Heptares to Present at Upcoming Scientific and Biotech Industry Conferences
10. “Scientific And Medical Research On The Successful Treatment Of Type 1 + 2 Diabetes With Alkaline Reduced Water” is Reviewed in Today’s Bawell Water Ionizer Health Report
11. BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... - And Other Rising Companies - a ... Biologics  - Biosimilar Drug Producers - Your ... Who are the most important and promising ... potentials? Discover, in our updated survey, organisations, outlooks from ... forecasting. Visiongain,s new study analyses ...
(Date:5/3/2016)... ... May 03, 2016 , ... Nashville Fertility Center ... A contingency of reproductive endocrinologists, including Dr. George Hill at Nashville ... to help them build families. , Ovation Fertility is a nationwide network of ...
(Date:5/2/2016)... ... ... StarNet Communications Corp, ( http://www.starnet.com/ ) a leading publisher of remote Linux ... to its flagship X-Win32 PC X server. The new modules enable X-Win32 to ... over encrypted SSH. , Traditionally, users of PC X servers deploy the XDMCP protocol ...
(Date:4/29/2016)... ... April 29, 2016 , ... Proove ... excited to announce the launch of the Proove Health Foundation . The ... education to promote the use of personalized medicine for tackling the nation’s most-pressing ...
Breaking Biology Technology:
(Date:3/9/2016)... YORK , March 9, 2016 This ... and future states of the RNA Sequencing (RNA Seq) ... segments such as instruments, tools and reagents, data analysis, ... Analyze various segments of the RNA-Sequencing market such as ... services Identify the main factors affecting each segment and ...
(Date:3/8/2016)...   Valencell , the leading innovator in ... secured $11M in Series D financing. The investment ... fund being launched by UAE-based financial services company ... TDF Ventures and WSJ Joshua Fund. Valencell plans ... growth and accelerate its pioneering innovation in accurate ...
(Date:3/3/2016)... DE SOTO, Kansas , March 3, 2016 ... to offer Oncimmune,s Early CDT®-Lung, a blood test ... of lung cancer Early CDT®-Lung test to ... --> Early CDT®-Lung test to its clients ... Oncimmune, a leader in early cancer detection, today ...
Breaking Biology News(10 mins):